Answer
As a precautionary measure, it is preferable to avoid Oxbryta (voxelotor) during pregnancy because there are no or limited data on its use in pregnant women.
Sources for this answer
- Oxbryta 500 mg film-coated tabletsPfizer Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 5Document updated
Sources checked